Rod James
Rod James is a reporter with Secondaries Investor and also contributes to sister title PrivateEquityInternational.com. He is based in the London office. Prior to PEI, his roles included a stint as a freelancer covering fintech and transaction banking, CEEMEA capital markets reporter with EMEA Finance magazine, and editor of the Latin American political and economic risk team at IHS Global Insight.
PTP becomes a Pretty Tricky Proposition
PTP rules can prove a real pain to LPs that want to sell fund stakes. It’s worth GPs doing all they can to get around them.
How to reduce the cost of forex hedging
Michael Slain, co-head of Investec's European Funds group, discusses the heightened need for FX hedging and how private funds can do it without breaking the bank.
Updated indictment sheds new light on Abraaj case
The document paints a picture of deceit, bribery and personal enrichment at the collapsed emerging markets firm.
Friday: The waning power of carry
With carried interest losing its appeal, co-investments could be the key to retaining young talent, said panelists at Invest Europe's CFO Forum in Valencia.
Abraaj Group: Trials will shine an ever-brighter light on operational due diligence
The fallout from the firm's collapse will drive change.
PODCAST: How to avoid pitfalls in stapled deals
Blue chip managers are using stapled secondaries deals to boost fundraising and provide liquidity to LPs. In this 17-minute podcast, lawyers from Proskauer, Debevoise & Plimpton and MJ Hudson discuss how GPs and LPs should approach this increasing transaction type.
Abraaj’s Naqvi denied bail on flee fears
The size of the alleged fraud, the involvement of the US government and his high-level political connections in Pakistan make granting the Abraaj founder bail too great a risk, a UK court decided.
A courtroom drama that will turn up the due diligence heat
As the Abraaj case plays out in the criminal courts, the impact on private equity investors and the GP-LP relationship will become palpable.
Abraaj’s Vettivetpillai in jail pending £1m bail appeal
The former managing partner and head of impact appeared by video-link at Westminster Magistrates Court on fraud charges brought by the US government.
TIMELINE: What Abraaj did, according to the SEC
A timeline shows what Abraaj and founder Arif Naqvi are alleged to have done regarding the misappropriation of capital from its 2015-vintage Growth Markets Health Fund, according to the US regulator's complaint.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@peimedia.com.